What are the major opportunities in the Synagis market? What are the strategies for the Synagis market?

For detailed insights on the major opportunities and strategies in the Synagis market, Read More

How does the Synagis market relate to the overall economy and other similar markets?

For detailed insights on Synagis's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Synagis industry?

For detailed insights on the mergers and acquisitions in the Synagis industry, Read More

What are the key dynamics influencing the Synagis market growth? SWOT analysis of the Synagis market.

For detailed insights on the key dynamics influencing the Synagis market growth and SWOT analysis of the Synagis industry, Read More

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Synagis Global Market Report 2025

Name: Synagis Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Clinical Indication (Respiratory Syncytial Virus (RSV) Prophylaxis, Premature Infants With Bronchopulmonary Dysplasia (BPD), Congenital Heart Disease (CHD), Immunocompromised Infants And Children), By Formulation (50 Milligrams (mg)/0.5 Milliliters (mL), 100 Milligrams (mg)/1 Milliliters (mL)), By Distribution Channel (Wholesale Distributors, Online Retailers), By End-User (Pediatric, Adults)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Synagis Market?

Synagis (palivizumab) is a medication used to prevent serious lower respiratory tract infections caused by the respiratory syncytial virus (RSV) in high-risk infants and children. It is a monoclonal antibody that works by binding to the RSV virus, preventing it from entering and infecting cells in the respiratory system.

The main types of clinical indications for synagis are respiratory syncytial virus (RSV) prophylaxis, premature infants with bronchopulmonary dysplasia (BPD), congenital heart disease (CHD), and immunocompromised infants and children. Respiratory syncytial virus (RSV) prophylaxis involves preventive approaches, such as administering monoclonal antibodies like synagis, to lower the risk of RSV infections, especially in infants and young children at high risk. It is formulated in several ways, such as 50 milligrams (mg)/0.5 milliliters (ml) and 100 milligrams (mg)/1 milliliters (ml), and distributed through various distribution channels, including wholesale distributors and online retailers. It is used by several end users, such as pediatric and adults.

Synagis Market Size and growth rate 2025 to 2029: Graph

What Is The Synagis Market Size 2025 And Growth Rate?

The synagis market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing spending on chronic illnesses, increase in research and development investment, rising disease burden, increasing hospitalization, and Increasing prevalence of chronic respiratory conditions.

What Is The Synagis Market Growth Forecast?

The synagis market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising R&D expenditures, a rise in the prevalence of RSV, growing demand for personalized and telemedicine, a growing aging population, increasing pediatric population in emerging markets. Major trends in the forecast period include the development of RSV treatment, biosimilar development, clinical trial outcomes, advances in treatment and regulatory approvals, and the introduction of combination vaccines.

Book your 30 minutes free consultation with our research experts

How Is The Synagis Market Segmented?

The synagis market covered in this report is segmented –

1) By Clinical Indication: Respiratory Syncytial Virus (RSV) Prophylaxis; Premature Infants With Bronchopulmonary Dysplasia (BPD); Congenital Heart Disease (CHD); Immunocompromised Infants And Children

2) By Formulation: 50 Milligrams (mg)/0.5 Milliliters (mL); 100 Milligrams (mg)/1 Milliliters (mL)

3) By Distribution Channel: Wholesale Distributors; Online Retailers

4) By End-User: Pediatric; Adults

What Is Driving The Synagis Market? Rising Prevalence Of Chronic Respiratory Conditions Driving The Market Growth

The increasing prevalence of chronic respiratory conditions is expected to propel the growth of the synagis market going forward. Chronic respiratory conditions are prolonged illnesses that impact the lungs and airways, leading to ongoing breathing problems. The prevalence of chronic respiratory conditions can be attributed to several factors, including an aging population, smoking and lifestyle choices, genetic and occupational factors, and environmental pollution. Synagis (palivizumab) prevents severe respiratory syncytial virus (RSV) infections in high-risk infants and children, reducing complications and exacerbations in those with chronic respiratory conditions. For instance, in December 2023, according to a report published by Public Health Scotland, a Scotland-based government organization, the prevalence of doctor-diagnosed asthma was 16% in 2021 and increased to 17% in 2022. Therefore, the increasing prevalence of chronic respiratory conditions is driving the growth of the synagis market.

What Is Driving The Synagis Market? Impact Of Increasing Healthcare Expenditure On The Growth Of The Market

The increase in healthcare expenditure is significantly driving the growth of the synagis market in the future. Healthcare expenditure refers to the financial resources spent on providing healthcare services, including medical treatments, hospital care, medications, and preventive measures. The increase in healthcare expenditure can be attributed to several factors, including an aging population, rising chronic diseases, public health crises, and increased demand for services. Rising healthcare expenditure is facilitating increased investment in preventive treatments for high-risk infants and young children. As healthcare budgets grow, more funding is directed toward medications such as synagis, helping to prevent severe respiratory illnesses. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure increased by 5.6% in nominal terms between 2022 and 2023, compared with growth of 0.9% in 2022. Therefore, the increase in healthcare expenditure is driving the growth of the synagis market.

Who Are The Major Players In The Global Synagis Market?

Major companies operating in the synagis market are Swedish Orphan Biovitrum AB

What Are The Key Trends Of The Global Synagis Market? First-Line Defense Against Respiratory Syncytial Virus (RSV) Now Accessible For High-Risk Infants

The key trend in the synagis market is obtaining drug approval by authorities to gain a long-awaited preventive therapy for respiratory syncytial virus. Drug approval is the process by which regulatory authorities evaluate and authorize a new drug for sale and use, ensuring its safety, efficacy, and quality based on clinical trial data. For instance, in September 2023, AstraZeneca Pharma India Ltd., an India-based biopharmaceutical company, obtained approval from the Central Drugs Standard Control Organisation (CDSCO) to market palivizumab, a preventive therapy for respiratory syncytial virus (RSV). This injection covers the palivizumab 100 mg/ml injection, which is available in 50 mg/0.5 ML and 100 mg/ml presentations in single-dose vials for intramuscular administration. Palivizumab is indicated for use in infants born at 35 weeks of gestation or less, children requiring treatment for bronchopulmonary dysplasia (BPD), and those with hemodynamically significant congenital heart disease (CHD). This approval marks an important step in improving RSV care in India, as it is the first preventive therapy for RSV available in the country.

Need data on a specific region in this market?

Request Regional Data

Regional Analysis For The Global Synagis Market

North America was the largest region in the synagis market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the synagis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the synagis market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Synagis Market?

The synagis market consists of sales of pre-filled, single-dose vials and injectable solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Synagis Industry?

The synagis market research report is one of a series of new reports from The Business Research Company that provides synagis market statistics, including the synagis industry global market size, regional shares, competitors with the synagis market share, detailed synagis market segments, market trends, and opportunities, and any further data you may need to thrive in the synagis industry. This synagis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abhilash Pyata

Synagis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included ?
Revenue Forecast In 2034	Included ?
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The synagis market covered in this report is segmented – 1) By Clinical Indication: Respiratory Syncytial Virus (RSV) Prophylaxis; Premature Infants With Bronchopulmonary Dysplasia (BPD); Congenital Heart Disease (CHD); Immunocompromised Infants And Children 2) By Formulation: 50 Milligrams (mg)/0.5 Milliliters (mL); 100 Milligrams (mg)/1 Milliliters (mL) 3) By Distribution Channel: Wholesale Distributors; Online Retailers 4) By End-User: Pediatric; Adults
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Swedish Orphan Biovitrum AB
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Synagis Market Characteristics

3. Synagis Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Synagis Market Trends And Strategies

5. Synagis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Synagis Growth Analysis And Strategic Analysis Framework

6.1. Global Synagis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Synagis Market Growth Rate Analysis

6.4. Global Synagis Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Synagis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Synagis Total Addressable Market (TAM)

7. Global Synagis Pricing Analysis & Forecasts

8. Synagis Market Segmentation

8.1. Global Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Respiratory Syncytial Virus (RSV) Prophylaxis

Premature Infants With Bronchopulmonary Dysplasia (BPD)

Congenital Heart Disease (CHD)

Immunocompromised Infants And Children

8.2. Global Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

50 Milligrams (mg)/0.5 Milliliters (mL)

100 Milligrams (mg)/1 Milliliters (mL)

8.3. Global Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Wholesale Distributors

Online Retailers

8.4. Global Synagis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Pediatric

Adults

9. Global Synagis Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Synagis Market Regional And Country Analysis

10.1. Global Synagis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Synagis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Synagis Market

11.1. Asia-Pacific Synagis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Synagis Market

12.1. China Synagis Market Overview

12.2. China Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Synagis Market

13.1. India Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Synagis Market

14.1. Japan Synagis Market Overview

14.2. Japan Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Synagis Market

15.1. Australia Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Synagis Market

16.1. South Korea Synagis Market Overview

16.2. South Korea Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Synagis Market

17.1. Western Europe Synagis Market Overview

17.2. Western Europe Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Synagis Market

18.1. UK Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Synagis Market

19.1. Germany Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Synagis Market

20.1. France Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Synagis Market

21.1. Eastern Europe Synagis Market Overview

21.2. Eastern Europe Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Synagis Market

22.1. North America Synagis Market Overview

22.2. North America Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Synagis Market

23.1. USA Synagis Market Overview

23.2. USA Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Synagis Market

24.1. Canada Synagis Market Overview

24.2. Canada Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Synagis Market

25.1. South America Synagis Market Overview

25.2. South America Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Synagis Market

26.1. Middle East Synagis Market Overview

26.2. Middle East Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Synagis Market

27.1. Africa Synagis Market Overview

27.2. Africa Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Synagis Market Competitive Landscape And Company Profiles

28.1. Synagis Market Competitive Landscape

28.2. Synagis Market Company Profiles

28.2.1. Swedish Orphan Biovitrum AB Overview, Products and Services, Strategy and Financial Analysis

29. Global Synagis Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Synagis Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Synagis Market

32. Recent Developments In The Synagis Market

33. Synagis Market High Potential Countries, Segments and Strategies

33.1 Synagis Market In 2029 - Countries Offering Most New Opportunities

33.2 Synagis Market In 2029 - Segments Offering Most New Opportunities

33.3 Synagis Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Synagis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Synagis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Global Synagis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: Asia-Pacific, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: China, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: India, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Japan, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: Australia, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: South Korea, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: Western Europe, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: UK, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: Germany, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: France, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: Eastern Europe, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: North America, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: USA, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: Canada, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: South America, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Middle East, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Africa, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 60: Swedish Orphan Biovitrum AB Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Synagis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Synagis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Global Synagis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: Asia-Pacific, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: China, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: India, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Japan, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: Australia, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: South Korea, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: Western Europe, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: UK, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: Germany, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: France, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: Eastern Europe, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: North America, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: USA, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: Canada, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: South America, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Middle East, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Synagis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Synagis Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Africa, Synagis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 60: Swedish Orphan Biovitrum AB Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Antisense And RNAi Therapeutics Market 2021- By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous injections, Intra Dermal injunctions, Other delivery methods), By Indication (Oncology...

Respiratory Devices And Equipment (Therapeutic And Diagnostic) Global Market Report 2025 – By Type (Diagnostic devices, Therapeutic devices, Monitoring devices), By Therapeutic Devices (Humidifiers, Nebulizers, Oxygen co...

Respiratory Disposables Global Market Report 2025 – By Type (Masks, Tubes, Inhalers, Other Types), By Disease Indications (Asthma, Chronic Obstructive Pulmonary Disorder, Tuberculosis, Lung Cancer, Other Chronic Respirat...

Respiratory Devices And Equipment (Therapeutic) Global Market Report 2025 – By Product (Nebulizers, Humidifiers, Oxygen Concentrators, Positive Airway Pressure Devices, Ventilators, Capnographs, Gas Analyzers), By Techno...

Respiratory Monitoring Devices Global Market Report 2025 – By Type (Capnographs, Gas Analyzers, Pulse Oximeters, Peak Flow Meters, Spirometers, Polysomnographs, Others Types), By Application (Chronic Obstructive Pulmonar...

Respiratory Devices And Equipment (Diagnostic) Global Market Report 2025 – By Product (Instruments And Devices, Assays And Reagents), By Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests, Molecular...

Anesthesia And Respiratory Devices Global Market Report 2025 – By Type (Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables), By Type of Ex...

Frequently Asked Questions

What is the definition of the Synagis market?

How will the Synagis market drivers and restraints affect the market dynamics? What forces will shape the Synagis industry going forward?

The Synagis market major growth driver - Rising Prevalence Of Chronic Respiratory Conditions Driving The Market Growth. For further insights on the Synagis market, request a sample here

What is the forecast market size or the forecast market value of the Synagis market?

The Synagis market size has grown strongly in recent years. The synagis market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing spending on chronic illnesses, increase in research and development investment, rising disease burden, increasing hospitalization, and Increasing prevalence of chronic respiratory conditions. The synagis market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising R&D expenditures, a rise in the prevalence of RSV, growing demand for personalized and telemedicine, a growing aging population, increasing pediatric population in emerging markets. Major trends in the forecast period include the development of RSV treatment, biosimilar development, clinical trial outcomes, advances in treatment and regulatory approvals, and the introduction of combination vaccines. For further insights on the Synagis market, request a sample here

How is the Synagis market segmented?

The synagis market covered in this report is segmented –
1) By Clinical Indication: Respiratory Syncytial Virus (RSV) Prophylaxis; Premature Infants With Bronchopulmonary Dysplasia (BPD); Congenital Heart Disease (CHD); Immunocompromised Infants And Children
2) By Formulation: 50 Milligrams (mg)/0.5 Milliliters (mL); 100 Milligrams (mg)/1 Milliliters (mL)
3) By Distribution Channel: Wholesale Distributors; Online Retailers
4) By End-User: Pediatric; Adults For further insights on the Synagis market, request a sample here

Which region has the largest share of the Synagis market? What are the other regions covered in the report?

Who are the major players in the Synagis market?

Major companies operating in the synagis market are Swedish Orphan Biovitrum AB . For further insights on the Synagis market, request a sample here.

What are the key trends in the Synagis market?

Major trends in the Synagis market include First-Line Defense Against Respiratory Syncytial Virus (RSV) Now Accessible For High-Risk Infants. For further insights on the Synagis market, request a sample here.